Guardant Health Inc [GH] stock is trading at $32.65, up 5.39%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GH shares have gain 12.16% over the last week, with a monthly amount glided 61.63%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on June 28, 2024, when Guggenheim upgraded its rating to a Buy but kept the price target unchanged to $36 for it. Guggenheim started tracking the stock assigning a Neutral rating. Wolfe Research initiated its recommendation with a Peer Perform. Raymond James upgraded its rating to Outperform for this stock on November 13, 2023, but kept the price target unchanged to $27. In a note dated September 28, 2023, Bernstein initiated an Outperform rating and provided a target price of $34 on this stock.
Guardant Health Inc [GH] stock has fluctuated between $15.81 and $37.04 over the past year. Currently, Wall Street analysts expect the stock to reach $57.27 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $32.65 at the most recent close of the market. An investor can expect a potential return of 75.41% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 692.26M for the trailing twelve months, which represents a growth of 33.87%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at -0.74%, Pretax Profit Margin comes in at -0.74%, and Net Profit Margin reading is -0.74%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -12.4 and Total Capital is -0.38. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-19.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 31.17 points at the first support level, and at 29.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.79, and for the 2nd resistance point, it is at 34.93.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 6.22. Also, the Quick Ratio is 5.85, while the Cash Ratio stands at 3.49. Considering the valuation of this stock, the price to sales ratio is 6.14.
Transactions by insiders
Recent insider trading involved Kalia Kumud, Chief Information Officer, that happened on Nov 18 ’24 when 7000.0 shares were sold. Officer, Kalia Kumud completed a deal on Nov 18 ’24 to buy 7000.0 shares. Meanwhile, Director Joyce Meghan V. sold 2896.0 shares on Nov 13 ’24.
